Neurology & psychiatry

Antiomal

Levetiracetam

INN

Levetiracetam

Dosage form

Film-coated tablets

Therapeutic area

Neurology & psychiatry

Indications

ANTIOMAL is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy. ANTIOMAL is indicated as adjunctive therapy: - in the treatment of partial-onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

Presentations

Information intended for healthcare professionals. Prescription-only medicine in accordance with current regulations: read the package leaflet carefully. Translation provided for information only. Only the package leaflet approved in the country of marketing is authoritative.